These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16283325)

  • 1. Oxalate and its handling in a low stone risk vs a stone-prone population group.
    Lewandowski S; Rodgers AL; Laube N; von Unruh G; Zimmermann D; Hesse A
    World J Urol; 2005 Nov; 23(5):330-3. PubMed ID: 16283325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects.
    Lewandowski S; Rodgers A; Schloss I
    BJU Int; 2001 Mar; 87(4):307-11. PubMed ID: 11251520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation: evidence of different renal handling mechanisms in different race groups.
    Rodgers AL; Lewandowski S
    J Urol; 2002 Sep; 168(3):931-6. PubMed ID: 12187193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithogenic risk factors in the urine of black and white subjects.
    Whalley NA; Moraes MF; Shar TG; Pretorius SS; Meyers AM
    Br J Urol; 1998 Dec; 82(6):785-90. PubMed ID: 9883212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA; Kullin B; Lewandowski S; Rodgers A; Reid SJ; Abratt VR
    J Appl Microbiol; 2012 Aug; 113(2):418-28. PubMed ID: 22616725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal response to lithogenic and anti-lithogenic supplement challenges in a stone-free population group.
    Lewandowski S; Rodgers AL
    J Ren Nutr; 2004 Jul; 14(3):170-9. PubMed ID: 15232796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of dietary calcium and oxalate ratios on stone risk.
    Lange JN; Wood KD; Mufarrij PW; Callahan MF; Easter L; Knight J; Holmes RP; Assimos DG
    Urology; 2012 Jun; 79(6):1226-9. PubMed ID: 22480460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate urolithiasis: significance of serum and urinary oxalate.
    Butz M; Kohlbecker G
    Urol Int; 1980; 35(4):303-8. PubMed ID: 7394936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for renal calcium stone formation in South African and European young adults.
    Rodgers A; Allie-Hamdulay S; Pinnock D; Baretta G; Trinchieri A
    Arch Ital Urol Androl; 2009 Sep; 81(3):171-4. PubMed ID: 19911680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.
    Robertson WG; Peacock M; Marshall RW; Marshall DH; Nordin BE
    N Engl J Med; 1976 Jan; 294(5):249-52. PubMed ID: 1244550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C; Larsson L; Tiselius HG
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers.
    Butz M; Hoffmann H; Kohlbecker G
    Urol Int; 1980; 35(5):309-15. PubMed ID: 7423675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate metabolism and renal calculi.
    Menon M; Mahle CJ
    J Urol; 1982 Jan; 127(1):148-51. PubMed ID: 7035692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
    Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
    Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.